The Supreme Court will once again weigh in on the abortion debate this upcoming term with the justices this time hearing a case that could limit access to an abortion pill known as Mifepristone.
The case centers around how the Food and Drug Administration (FDA) allows the pill to be prescribed.
It was approved for use in a controversial manner 23 years ago. That approval required an in-person prescription, but the abortion-inducing drug has been available through telemedicine and by mail since 2016. Critics say that puts women’s lives at risk because a doctor can’t fully assess them.
This is the first abortion case the court will hear since the monumental Dobbs decision that overturned Roe v. Wade in 2022.
As CBN News reported in August, the Fifth Circuit Court of Appeals ruled that the Food and Drug Administration (FDA) was wrong to remove safety measures for mifepristone.
“In loosening mifepristone’s safety restrictions, FDA failed to address several important concerns about whether the drug would be safe for the women who use it,” Judge Jennifer Walker Elrod wrote. She was joined by Judge Cory Wilson.
In its ruling, the court restored other safety measures to protect women, saying mifepristone should only
The remainder of this article is available in its entirety at CBN